Results 91 to 100 of about 166,756 (292)

Interrogating the immune landscape of microsatellite stable RAS‐mutated colon cancer

open access: yesMolecular Oncology, EarlyView.
COLOSSUS project RAS‐mutated MSS colon cancer study explored transcriptomics and immune cell density by immunohistochemistry (IHC), Immunoscore (IS), ISIC/TuLIS scores, mutation counts, and detected different prevalences but similar microenvironment composition across immune markers with clinical relevance for future immunotherapy combination ...
Rodrigo Dienstmann   +61 more
wiley   +1 more source

IMPDH inhibition enhances cytarabine efficacy in SAMHD1‐expressing leukaemia cells via guanine nucleotide depletion

open access: yesMolecular Oncology, EarlyView.
Cytarabine is a key therapy for acute myeloid leukaemia (AML), but its efficacy is limited by the dNTPase SAMHD1, which hydrolyses its active metabolite. Screening nucleotide biosynthesis inhibitors revealed that IMPDH inhibitors selectively sensitise SAMHD1‐proficient AML cells to cytarabine.
Miriam Yagüe‐Capilla   +9 more
wiley   +1 more source

Manuscript Success and Choosing a Topic

open access: yes
Successful manuscript writing hinges on careful planning, particularly in selecting a compelling topic. Key steps include journal diligence, template analysis, and drafting. Authors should focus on engaging topics that resonate with editors. Ultimately, effective topic selection enhances the likelihood of publication, leading to a rewarding writing ...
openaire   +1 more source

KDM7A and KDM1A inhibition suppresses tumour promoting pathways in prostate cancer

open access: yesMolecular Oncology, EarlyView.
Treatment resistance is a major challenge for patients with advanced prostate cancer. This study examined an alternative approach to target the major prostate cancer‐promoting pathway by targeting epigenetic factors, whose levels are higher in tumours.
Jennie N Jeyapalan   +16 more
wiley   +1 more source

A kolozsvári Babeş–Bolyai Tudományegyetem Bölcsészettudományi Kar Magyar és Általános Nyelvészeti Tanszéke könyvtárának névtani tárgyú kéziratai

open access: yesNévtani Értesítő, 2014
Onomastic manuscripts at the Library of the Department of Hungarian and General Linguistics in Babeş–Bolyai University, Cluj-Napoca, Romania     This paper discusses the position of Onomastics in the curriculum of Hungarian higher education in ...
Magdolna Csomortáni
doaj  

Heterozygous loss‐of‐function alleles associate the conserved 3′‐5′ exoribonuclease EXOSC10 with hypersensitivity to the anticancer drug 5‐fluorouracil

open access: yesMolecular Oncology, EarlyView.
EXOSC10, an essential nuclear RNA exosome‐associated 3′‐5′ exoribonuclease, is inhibited by the anticancer drug 5‐fluorouracil (5‐FU), and EXOSC10 depletion increases 5‐FU sensitivity. The colon‐cancer variant EXOSC10S402T, located in a proteolysis motif, is stable and nuclear but nonfunctional in vivo.
Radhika Sain   +10 more
wiley   +1 more source

Beliefs and practices in health and disease from the Maclagan Manuscripts (1892–1903) [PDF]

open access: yes, 2014
The Maclagan Manuscripts (1892–1903) are derived from transcriptions of an extensive range of oral traditional narratives collected from a large number of named loci throughout the Highlands and Islands of Scotland, but principally from Argyllshire ...
Turner, Allan. R
core  

Methodological Issues in Macro Comparative Research: An Introduction

open access: yesJournal of World-Systems Research, 2015
This special issue of JWSR is the offspring of an ASA Political Economy of the World System session that I organized in 2007. My thanks to Andrew Jorgenson, co-editor of JWSR, who moderated the session and proposed that I put together a special issue on ...
Jeffrey Kentor
doaj   +1 more source

Longitudinal circulating tumor DNA profiling in patients with advanced endometrial cancer using an off‐the‐shelf targeted NGS panel

open access: yesMolecular Oncology, EarlyView.
Intratumour heterogeneity complicates precision management of advanced endometrial cancer. Circulating tumor DNA (ctDNA) offers a minimally invasive strategy to capture tumor evolution and therapeutic resistance. Here, we compare tumor‐agnostic NGS with tumor‐informed ddPCR, outlining their relative sensitivity, concordance, and clinical implications ...
Carlos Casas‐Arozamena   +15 more
wiley   +1 more source

Home - About - Disclaimer - Privacy